MDxHealth (MDxHealth) FCF Yield % : -45.34 (As of Apr. 29, 2024)

View and export this data going back to 2008. Start your Free Trial

What is MDxHealth FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, MDxHealth's Trailing 12-Month Free Cash Flow is $-30.56 Mil, and Market Cap is $67.40 Mil. Therefore, MDxHealth's FCF Yield % for today is -45.34%.

The historical rank and industry rank for MDxHealth's FCF Yield % or its related term are showing as below:

MDXH' s FCF Yield % Range Over the Past 10 Years
Min: -238451.48 Med: -31.37 Max: -5.56
Current: -45.34

During the past 13 years, the highest FCF Yield % of MDxHealth was -5.56%. The lowest was -238451.48%. And the median was -31.37%.

MDXH's FCF Yield % is ranked worse than
80.69% of 233 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.43 vs MDXH: -45.34

MDxHealth's FCF Margin % for the quarter that ended in Sep. 2023 was -26.56%.

MDxHealth FCF Yield % Historical Data

The historical data trend for MDxHealth's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MDxHealth FCF Yield % Chart

MDxHealth Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Yield %

Get a 7-Day Free Trial

-25.57

-28.82

-22.69

-14.45

-37.31

MDxHealth Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Yield %	Get a 7-Day Free Trial															-38.41	-48.45	-81,514.60	-32.56	-27.65

Competitive Comparison of MDxHealth's FCF Yield %

For the Diagnostics & Research subindustry, MDxHealth's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MDxHealth's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, MDxHealth's FCF Yield % distribution charts can be found below:

* The bar in red indicates where MDxHealth's FCF Yield % falls into.

MDxHealth FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

MDxHealth's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-38.281	/	102.61503
	=	-37.31%

MDxHealth's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-5.14	*	4	/	74.354775
	=	-27.65%

MDxHealth FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

MDxHealth FCF Yield % Related Terms

Thank you for viewing the detailed overview of MDxHealth's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

MDxHealth (MDxHealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » MDxHealth SA (NAS:MDXH) » Definitions » FCF Yield %

Comparable Companies

BIOQ PSNL VNRX PRE ENZ PRPH ACRS BNR DRIO AWH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

N/A

Address

Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040

Website

https://www.mdxhealth.com

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.